PROLONGED COMPOUND MUSCLE ACTION POTENTIAL DURATION IN CRITICAL ILLNESS MYOPATHY

被引：37

作者：

Goodman, Brent P. ^{[2
]}

Harper, C. Michel ^{[3
]}

Boon, Andrea J. ^{[1
]}

机构：

[1] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA

[2] Mayo Clin, Dept Neurol, Scottsdale, AZ USA

[3] Mayo Clin, Dept Neurol, Rochester, MN USA

来源：

MUSCLE & NERVE | 2009年 / 40卷 / 06期

关键词：

critical illness; myopathy; compound muscle action potential; CMAP; duration; ACUTE QUADRIPLEGIC MYOPATHY; INTENSIVE-CARE-UNIT; EXCITABILITY; WEAKNESS; STEROIDS; AGENTS; MODEL;

D O I：

10.1002/mus.21445

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Critical illness myopathy (CIM) is a frequent cause of generalized weakness in the intensive care unit. Prolonged compound muscle action potential (CMAP) durations have been described in this patient population, and this study presents further data on CMAP duration in normal controls and patients with CIM. The findings highlight the importance of testing multiple nerve muscle combinations in weak, critically ill patients. Recognition of this pattern, which has not been widely described, can facilitate the diagnosis of CIM. Muscle Nerve 40: 1040-1042, 2009

引用

页码：1040 / 1042

页数：3

共 20 条

[1] Critical illness myopathy: Further evidence from muscle-fiber excitability studies of an acquired channelopathy [J].

Allen, David C. ;

Arunachalam, Ramamurthy ;

Mills, Kerry R. .

MUSCLE & NERVE, 2008, 37 (01) :14-22

[2] Critical illness myopathy and polyneuropathy [J].

Bird S.J. ;

Rich M.M. .

Current Neurology and Neuroscience Reports, 2002, 2 (6) :527-533

[3] Neuromuscular manifestations of critical illness [J].

Bolton, CF .

MUSCLE & NERVE, 2005, 32 (02) :140-163

[4]

DAUBE JR, 2002, CLIN NEUROPHYSIOLOGY

[5] Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle [J].

Friedrich, O ;

Hund, E ;

Weber, C ;

Hacke, W ;

Fink, RHA .

JOURNAL OF NEUROLOGY, 2004, 251 (01) :53-65

[6] ACUTE QUADRIPLEGIC MYOPATHY - A COMPLICATION OF TREATMENT WITH STEROIDS, NONDEPOLARIZING BLOCKING-AGENTS, OR BOTH [J].

HIRANO, M ;

OTT, BR ;

RAPS, EC ;

MINETTI, C ;

LENNIHAN, L ;

LIBBEY, NP ;

BONILLA, E ;

HAYS, AP .

NEUROLOGY, 1992, 42 (11) :2082-2087

[7] Acute quadriplegic myopathy unrelated to steroids or paralyzing agents:: Quantitative EMG studies [J].

Höke, A ;

Rewcastle, NB ;

Zochodne, DW .

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 (04) :325-329

[8] Acute myopathy of intensive care: Clinical, electromyographic, and pathological aspects [J].

Lacomis, D ;

Giuliani, MJ ;

VanCott, A ;

Kramer, DJ .

ANNALS OF NEUROLOGY, 1996, 40 (04) :645-654

[9]

Lacomis D, 1998, MUSCLE NERVE, V21, P610, DOI 10.1002/(SICI)1097-4598(199805)21:5<610::AID-MUS7>3.0.CO

[10]

2-B

← 1 2 →